If a person has a Medicare Part D prescription drug plan, it may cover the costs of Trelegy Ellipta inhalers. Although out-of-pocket costs can vary by plan ...

Trelegy Ellipta approved as the first once-daily single inhaler triple therapy for the treatment of appropriate patients with COPD in the US GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc.

The cost of Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) can vary based on several factors, including your insurance coverage. Coupons and drug savings ...

Edited by ad hoc news New Releases & Launches Desk. Reviewed before publication on 06/15/2026 at 9:30 PM ET. Details in the imprint. With its once-daily inhaler Trelegy Ellipta, GSK is pushing deeper ...